Smruthi Organics Limited is an India-based active pharmaceutical ingredients (API) manufacturer serving pharmaceutical companies. The Company’s segments include Bulk Drugs and Drugs Intermediates and Formulation. It manufactures API products in the anti-diabetic, anti-hypertension and anti-infectives therapeutic categories. Its products include Amlodipine Besilate, Losartan Potassium, Telmisartan, Metformin HCL, S-Amlodipine Besilate, S-Amlodipine Malelate, Valsartan, Vildagliptin, Teneligliptin, Ciprofloxacin HCL, Diloxanide Furoate, Norfloxacin, Pefloxacin Mesylate, Ticagrelor, and others. It caters to both the Indian domestic as well as the rest of the world (ROW) markets, with clients spanning Asia, the Americas, and Africa. The Company has two manufacturing facilities in Solapur, India. The API facility is spread across 22-acre land.As of 25 May 2026, Smruthi Organics Limited share price is ₹119.20. The stock opened at ₹122.75, compared to its previous close of ₹119.00. During today's trading session, Smruthi Organics Limited share price moved in the range of ₹117.15 to ₹122.75, with an average price of ₹119.95 for the day. Looking at its last 52-week, the stock has touched a low of ₹117.15 and a high of ₹122.75.
The market capitalization of Smruthi Organics Limited is ₹136 Crs, with a P/E ratio of 39.8 and a dividend yield of 0.00%.